Iris Alroy

Dr. Iris Alroy

Anima Biotech, Ltf., Ramat Gan, Tel Aviv, Israel
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 1999 in Molecular Cell
Verified
Journal Article
Closed access
GLGil Levkowitz
Gil Levkowitz
HWHadassa Waterman
Hadassa Waterman
SESeth A Ettenberg
Seth A Ettenberg
MKMenachem Katz
Menachem Katz
ATAlexander Y Tsygankov
Alexander Y Tsygankov
YYYosef Yarden
Yosef Yarden

1 May 1996 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
RPR. Pinkas‐Kramarski
R. Pinkas‐Kramarski
LSL. Soussan
L. Soussan
HWH. Waterman
H. Waterman
GLG. Levkowitz
G. Levkowitz
Iris AlroyIris Alroy
Iris Alroy
YYY. Yarden
Y. Yarden
The ErbB family includes two receptors, ErbB-1 and ErbB-3, that respectively bind to epidermal growth factor and Neu differentiation factor, and an orphan receptor, ErbB-2. Unlike ErbB-1 and ErbB-2, the intrinsic tyrosine kinase of ErbB-3 is catalytically impaired. By using interleukin-3-dependent cells that ectopically express the three ErbB proteins or their combinations, we found that ErbB-3 is devoid of any biological activity but both ErbB-1 and ErbB-2 can reconstitute its extremely potent mitogenic activity. Transactivation of ErbB-3 correlates with heterodimer formation and is reflected in receptor phosphorylation and the transregulation of ligand affinity. Inter-receptor interactions enable graded proliferative and survival signals: heterodimers are more potent than homodimers, and ErbB-3-containing complexes, especially the ErbB-2/ErbB-3 heterodimer, are more active than ErbB-1 complexes. Nevertheless, ErbB-1 signaling displays dominance over ErbB-3 when the two receptors are coexpressed. Although all receptor combinations activate the mitogen-activated protein kinases ERK and c-Jun kinase, they differ in their rate of endocytosis and in coupling to intervening signaling proteins. It is conceivable that combinatorial receptor interactions diversify signal transduction and confer double regulation, in cis and in trans, of the superior mitogenic activity of the kinase-defective ErbB-3.

1 October 1995 in Molecular and Cellular Biology
Verified
Journal Article
Open access
PDF file
Iris AlroyIris Alroy
Iris Alroy
TTTerri L. Towers
Terri L. Towers
LFLeonard P. Freedman
Leonard P. Freedman
T-lymphocyte proliferation is suppressed by 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], the active metabolite of vitamin D3, and is associated with a decrease in interleukin 2 (IL-2), gamma interferon, and granulocyte-macrophage colony-stimulating factor mRNA levels. We report here that 1,25(OH)2D3-mediated repression in Jurkat cells is cycloheximide resistant, suggesting that it is a direct transcriptional repressive effect on IL-2 expression by the vitamin D3 receptor (VDR). We therefore examined vitamin D3-mediated repression of activated IL-2 expression by cotransfecting Jurkat cells with IL-2 promoter/reporter constructs and a VDR overexpression vector and by DNA binding. We delineated an element conferring both DNA binding by the receptor in vitro and 1,25(OH)2D3-mediated repression in vivo to a short 40-bp region encompassing an important positive regulatory element, NF-AT-1, which is bound by a T-cell-specific transcription factor, NFATp, as well as by AP-1. VDR DNA-binding mutants were unable to either bind to this element in vitro or repress in vivo; the VDR DNA-binding domain alone, however, bound the element but also could not repress IL-2 expression. These results indicate that DNA binding by VDR is necessary but not sufficient to mediate IL-2 repression. By combining partially purified proteins in vitro, we observed the loss of the bound NFATp/AP-1-DNA complex upon inclusion of VDR or VDR-retinoid X receptor. Order of addition and off-rate experiments indicate that the VDR-retinoid X receptor heterodimer blocks NFATp/AP-1 complex formation and then stably associates with the NF-AT-1 element. This direct inhibition by a nuclear hormone receptor of transcriptional activators of the IL-2 gene may provide a mechanistic explanation of how vitamin derivatives can act as potent immunosuppressive agents.

1 August 1999 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
HWHadassa Waterman
Hadassa Waterman
GLGil Levkowitz
Gil Levkowitz
Iris AlroyIris Alroy
Iris Alroy
YYYosef Yarden
Yosef Yarden
Ligand-induced activation of surface receptors, including the epidermal growth factor receptor (EGFR), is followed by a desensitization process involving endocytosis and receptor degradation. c-Cbl, a tyrosine phosphorylation substrate shared by several signaling pathways, accelerates desensitization by recruiting EGFR and increasing receptor polyubiquitination. Here we demonstrate that the RING type zinc finger of c-Cbl is essential for ubiquitination and subsequent desensitization of EGFR. Mutagenesis of a single cysteine residue impaired the ability of c-Cbl to enhance both down-regulation and ubiquitination of EGFR in living cells, although the mutant retained binding to the activated receptor. Consequently, the mutant form of c-Cbl acquired a dominant inhibitory function and lost the ability to inhibit signaling downstream to EGFR. In vitroreconstitution of EGFR ubiquitination implies that the RING finger plays an essential direct role in ubiquitin ligation. Our results attribute to the RING finger of c-Cbl a causative role in endocytic sorting of EGFR and desensitization of signal transduction.

15 May 2002 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
ACAmi Citri
Ami Citri
Iris AlroyIris Alroy
Iris Alroy
SLSara Lavi
Sara Lavi
CRChanan Rubin
Chanan Rubin
WXWanping Xu
Wanping Xu
YYYosef Yarden
Yosef Yarden
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

15 August 1997 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
ETEldad Tzahar
Eldad Tzahar
RPRonit Pinkas‐Kramarski
Ronit Pinkas‐Kramarski
JMJames D. Moyer
James D. Moyer
LKLeah N. Klapper
Leah N. Klapper
Iris AlroyIris Alroy
Iris Alroy
YYYosef Yarden
Yosef Yarden
Signaling by epidermal growth factor (EGF)‐like ligands is mediated by an interactive network of four ErbB receptor tyrosine kinases, whose mechanism of ligand‐induced dimerization is unknown. We contrasted two existing models: a conformation‐driven activation of a receptor‐intrinsic dimerization site and a ligand bivalence model. Analysis of a Neu differentiation factor (NDF)‐induced heterodimer between ErbB‐3 and ErbB‐2 favors a bivalence model; the ligand simultaneously binds both ErbB‐3 and ErbB‐2, but, due to low‐affinity of the second binding event, ligand bivalence drives dimerization only when the receptors are membrane anchored. Results obtained with a chimera and isoforms of NDF/neuregulin predict that each terminus of the ligand molecule contains a distinct binding site. The C‐terminal low‐affinity site has broad specificity, but it prefers interaction with ErbB‐2, an oncogenic protein acting as a promiscuous low‐affinity subunit of the three primary receptors. Thus, ligand bivalence enables signal diversification through selective recruitment of homo‐ and heterodimers of ErbB receptors, and it may explain oncogenicity of erbB‐2/HER2.